Sort
141,003 grants matching “cytokine”
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2019 · DK
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · SB1 · FY2023 · AI
Preclinical development of an immunomodulatory agent capable of mitigating SARS-CoV-2 virus related hypercytokinemia
$1,000,000Jodi K Craigo · Cytoagents, Inc. · R44 · FY2021 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · R44 · FY2021 · AI
Advanced generation infection-proof anti-HIV CAR-T with YY1 RNAi to block T cell exhaustion in NHP model
$1,000,000Richard P Junghans · It Bio, Llc · R44 · FY2023 · AI
GASTROINTESTINAL HORMONE RESEARCH CORE CENTER
$1,000,000University Of Michigan At Ann Arbor · P30 · FY2005 · DK
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics
$999,999Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2012 · DK
Chronic Kidney Disease in Children (CKiD)
$999,999Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2008 · DK
SIRPant Technology for anti-Cancer Immunity
$999,999Nathanael McCurley · Bobcatbio, Inc. · R42 · FY2024 · CA
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
$999,999Robert Segal · Discovery Laboratories, Inc. · R44 · FY2014 · AI
Soluble high-affinity T cell receptors prevent MRSA lethality
$999,999Adam Chervin · Immuven, Inc. · R44 · FY2012 · AI
Enabling Technology to Prepare Ultrapure Dialysate in Dialysis Clinics
$999,999Mohamed E Labib · Novaflux Technologies, Inc. · R44 · FY2013 · DK
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia
$999,997Atul Varadhachary · Fannin Partners, Llc · R44 · FY2022 · CA
Development of GIFT4: a B cell focused immunotherapy for cancer
$999,997Paul Guyre · Celdara Medical, Llc · R44 · FY2018 · CA
Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia
$999,997Atul Varadhachary · Fannin Partners, Llc · R44 · FY2025 · CA
Preclinical evaluation of a novel small molecule STAT inhibitor
$999,993Robert Sons · Fannin Partners, Llc · R44 · FY2018 · AI
CMC of Peptide Formulation for the Treatment of ARDS
$999,993Gerardo M. Castillo · Pharmain Corporation · R44 · FY2022 · HL
Data Coordinating Center for PKD Treatment Network
$999,991Washington University · U01 · FY2003 · DK
Targeting lipid rafts for treatment of asthma
$999,991Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2023 · AI
A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
$999,989Neil A Fanger · Virtici, Llc · R44 · FY2025 · HL
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$999,965Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2021 · HL
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
$999,953Abigail Pulsipher · Glycomira, Llc · R44 · FY2021 · AI
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
$999,945Jay Edward Wrobel · Fox Chase Chemical Diversity Center, Inc · R44 · FY2019 · HL
Factor XII Inhibitor for Surface Initiated Thrombosis
$999,930Erik Ian Tucker · Aronora, Inc. · R44 · FY2020 · HL
Novel Strategies to Clear Bacteria from the CF Lung
$999,919Saira Ahmad · Eldec Pharmaceuticals, Inc. · R44 · FY2022 · HL